Lista de obras -

2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.

artículo científico publicado en 2013

2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative

artículo científico publicado en 2013

Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator-Initiated, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial

artículo científico publicado en 2019

Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers

artículo científico publicado en 2002

COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD

scientific article published on 02 April 2020

Distinct expression of adhesion molecules on skin fibroblasts from patients with diffuse and limited systemic sclerosis. A pilot study

artículo científico publicado en 2005

Effects of rituximab in connective tissue disorders related interstitial lung disease

artículo científico publicado en 2016

Elevated serum levels of sonic hedgehog are associated with fibrotic and vascular manifestations in systemic sclerosis.

artículo científico publicado en 2017

European multicentre study validates enhanced liver fibrosis test as biomarker of fibrosis in systemic sclerosis

artículo científico publicado en 2019

Fibroblast growth factor receptor 3 activates a network of profibrotic signaling pathways to promote fibrosis in systemic sclerosis

scientific article published on 01 September 2020

Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR group.

artículo científico publicado en 2017

Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension

scientific article published on 09 December 2019

Heart non-specific effector CD4+ T cells protect from postinflammatory fibrosis and cardiac dysfunction in experimental autoimmune myocarditis

artículo científico publicado en 2019

Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort

scientific article published on 22 September 2020

Incidence and risk factors for gangrene in patients with systemic sclerosis from the EUSTAR cohort

artículo científico publicado en 2019

Involvement of the myeloid cell compartment in fibrogenesis and systemic sclerosis

scientific article published on 01 May 2019

Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise

artículo científico publicado en 2012

Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)

artículo científico publicado en 2020

Might Nailfold Capillaroscopy Be a "Proxy" for Lung Involvement in Connective Tissue Diseases?

scientific article published on 01 September 2019

Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease

artículo científico publicado en 2019

Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study

artículo científico publicado en 2019

Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis

scientific article published on 21 June 2019

Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis

artículo científico publicado en 2013

Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database

artículo científico publicado en 2020

Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort

artículo científico publicado en 2019

Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension

artículo científico publicado en 2013

Regulation of Fibroblast Apoptosis and Proliferation by MicroRNA-125b in Systemic Sclerosis

scientific article published on 01 November 2019

Response to: ' Correspondence on 'Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension'' by Iudici <i>et al</i>

artículo científico publicado en 2020

Response to: 'Correspondence on 'Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial'' by Bredemeier

scientific article published on 06 October 2020

Response to: 'Riociguat in systemic sclerosis: a potential for disease modification' by Jain and Dhir

scientific article published on 15 July 2020

Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrual

artículo científico publicado en 2019

Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial

artículo científico publicado en 2020

Safety and effectiveness of abatacept in systemic sclerosis: The EUSTAR experience

artículo científico publicado en 2020

Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial

artículo científico publicado en 2020

Serum Biomarkers for Connective Tissue and Basement Membrane Remodeling are Associated with Vertebral Endplate Bone Marrow Lesions as Seen on MRI (Modic Changes)

artículo científico publicado en 2020

Significant weight loss in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

artículo científico publicado en 2020

Stiff skin syndrome: evidence for an inflammation-independent fibrosis?

artículo científico publicado en 2009

Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management

artículo científico publicado en 2020

The challenge of Very Early Systemic Sclerosis: a Combination of Mild and Early Disease?

artículo científico publicado en 2020

Transforming growth factor-β-dependent Wnt secretion controls myofibroblast formation and myocardial fibrosis progression in experimental autoimmune myocarditis.

artículo científico publicado en 2016

Update of EULAR recommendations for the treatment of systemic sclerosis

artículo científico publicado en 2016

Validation of the suction device Nimble for the assessment of skin fibrosis in systemic sclerosis

scientific article published on 03 June 2020

Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR population

artículo científico publicado en 2015

Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the DeSScipher inception cohort study

artículo científico publicado en 2019

Lista de obras de

2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.

2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative

Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator-Initiated, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial

Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers

COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD

Distinct expression of adhesion molecules on skin fibroblasts from patients with diffuse and limited systemic sclerosis. A pilot study

Effects of rituximab in connective tissue disorders related interstitial lung disease

Elevated serum levels of sonic hedgehog are associated with fibrotic and vascular manifestations in systemic sclerosis.

European multicentre study validates enhanced liver fibrosis test as biomarker of fibrosis in systemic sclerosis

Fibroblast growth factor receptor 3 activates a network of profibrotic signaling pathways to promote fibrosis in systemic sclerosis

Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR group.

Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension

Heart non-specific effector CD4+ T cells protect from postinflammatory fibrosis and cardiac dysfunction in experimental autoimmune myocarditis

Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort

Incidence and risk factors for gangrene in patients with systemic sclerosis from the EUSTAR cohort

Involvement of the myeloid cell compartment in fibrogenesis and systemic sclerosis

Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise

Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)

Might Nailfold Capillaroscopy Be a "Proxy" for Lung Involvement in Connective Tissue Diseases?

Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease

Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study

Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis

Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis

Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database

Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort

Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension

Regulation of Fibroblast Apoptosis and Proliferation by MicroRNA-125b in Systemic Sclerosis

Response to: ' Correspondence on 'Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension'' by Iudici <i>et al</i>

Response to: 'Correspondence on 'Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial'' by Bredemeier

Response to: 'Riociguat in systemic sclerosis: a potential for disease modification' by Jain and Dhir

Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrual

Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial

Safety and effectiveness of abatacept in systemic sclerosis: The EUSTAR experience

Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial

Serum Biomarkers for Connective Tissue and Basement Membrane Remodeling are Associated with Vertebral Endplate Bone Marrow Lesions as Seen on MRI (Modic Changes)

Significant weight loss in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

Stiff skin syndrome: evidence for an inflammation-independent fibrosis?

Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management

The challenge of Very Early Systemic Sclerosis: a Combination of Mild and Early Disease?

Transforming growth factor-β-dependent Wnt secretion controls myofibroblast formation and myocardial fibrosis progression in experimental autoimmune myocarditis.

Update of EULAR recommendations for the treatment of systemic sclerosis

Validation of the suction device Nimble for the assessment of skin fibrosis in systemic sclerosis

Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR population

Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the DeSScipher inception cohort study